The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company's existing shot, but a second option. The new vaccine, ...
The U.S. Food and Drug Administration approved 2025-26 COVID-19 vaccines for anyone age 65 and older and any person 6 months and older who has at least one underlying health condition that increases ...
The Centers for Disease Control and Prevention has officially updated guidelines for COVID-19 and chickenpox vaccines based on recommendations made last month by the agency's vaccine advisory ...
Like it or not, COVID-19 is still a public health issue five years after the start of the pandemic flipped the nation, and the world, on its head. Here is a brief recap of the status of COVID cases, ...
If you're planning on getting a Covid-19 booster this fall, you could be faced with a hefty bill — even if you have insurance. Health and Human Services Secretary Robert F. Kennedy Jr. announced in ...
What Strain(s) Will The Vaccines Protect Against? The updated vaccines will target the JN.1 lineage of COVID-19, using the LP.8.1 strain. This lineage is a descendant of the Omicron variant of the ...
The FDA approved 2025-2026 COVID vaccines from Pfizer (Comirnaty), Moderna (Spikevax, mNexspike), and Novavax (Nuvaxovid), the companies announced on Wednesday. But the agency removed one of the ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. MIAMI, FLORIDA - MAY 29: In this photo illustration, Pfizer-BioNTech COVID-19 (L) and ...
It's an anniversary no one wants to celebrate, but an anniversary nonetheless. Thursday, March 19, marked six years since the first COVID-19 lockdown was implemented in the United States. And while it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results